Ability of Haemocoagulase-medicine to stop bleeding in children undergoing removal of milk teeth
Not Applicable
- Conditions
- Health Condition 1: null- 1. Healthy children2. Age group of 5-93. Reporting with Parents/Guardians4. Requiring dental extraction of bilateral deciduous molars of either maxillary or mandibular arch
- Registration Number
- CTRI/2017/09/009784
- Lead Sponsor
- nil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. ASA-I status (Healthy patients)
2. Reporting to OPD
3. Requiring dental extractions of any Bilateral deciduous molars of either maxillary or mandibular arch
Exclusion Criteria
1. Conditions contraindicating Haemocoagulase such as Disseminated Intravascular Coagulation or Afibrinogenemia
2. NSAID-use in previous 24 hours
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time taken for Complete cessation of bleedingTimepoint: Time taken for Complete cessation of bleeding
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What is the molecular mechanism of Haemocoagulase in promoting hemostasis during pediatric dental extractions?
How does topical Haemocoagulase compare to standard-of-care hemostatic agents like epinephrine in children's tooth extraction?
Are there specific biomarkers that indicate optimal response to Haemocoagulase in pediatric dental procedures?
What are the potential adverse events associated with Haemocoagulase application in deciduous tooth extraction?
What alternative hemostatic compounds or combination therapies are being explored for pediatric dental use alongside Haemocoagulase?